SCHEMBL1552913

SCHEMBL1552913

c1cnc2c(c1)SCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29804989 1.00
Azetidine SCHEMBL29188857 0.91 MEN1 (0.38)
SCHEMBL2511410 0.88 HPGD (0.40)
SCHEMBL31332387 0.75 RYR2 (0.53)
SCHEMBL31332390 0.75 RYR2 (0.53)
SCHEMBL31001735 0.71 ALDH1A1 (0.36)
SCHEMBL15539282 0.71 ALDH1A1 (0.36)
SCHEMBL2051657 0.71 GAA (0.50)
SCHEMBL10565253 0.69 KCNN4 (0.34)
SCHEMBL31243438 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022057142-A1 STEROID SYNTHETASE INHIBITORS AND THERAPEUTIC USE THEREOF 广州中医药大学(广州中医药研究院) 2022-03-24 WO claimed
CN-112079826-A Steroid synthetase inhibitor and treatment application thereof 广州中医药大学(广州中医药研究院) 2020-12-15 CN claimed
EP-2602242-A1 PROCESS FOR PREPARING COMPOUND BY NOVEL SANDMEYER-LIKE REACTION USING NITROXIDE RADICAL COMPOUND AS REACTION CATALYST DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-06-12 EP claimed
US-20130144061-A1 PROCESS FOR PREPARING A COMPOUND BY A NOVEL SANDMEYER-LIKE REACTION USING A NITROXIDE RADICAL COMPOUND AS A REACTION CATALYST DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-06-06 US claimed
EP-1709052-B1 DERIVATIVES OF 1,4-DIAZABICYCLO 3.2.1OCTANECARBOXAMIDE, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS SANOFI AVENTIS (FR) 2011-04-27 EP claimed
US-20070155749-A1 DERIVATIVES OF 1,4-DIAZABICYCLO[3.2.1]OCTANECARBOXAMIDE, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS SANOFI-AVENTIS (FR) 2007-07-05 US claimed
US-20070123510-A1 Guanidine derivatives ACTELION PHARMACEUTICALS LTD. (CH) 2007-05-31 US claimed
JP-2007504176-A 2007-03-01 JP claimed
EP-1709052-A1 DERIVATIVES OF 1,4-DIAZABICYCLO 3.2.1OCTANECARBOXAMIDE, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS Sanofi-Aventis (FR) 2006-10-11 EP claimed
EP-1663993-A1 GUANIDINE DERIVATIVES Actelion Pharmaceuticals Ltd. (CH) 2006-06-07 EP claimed
WO-2005023781-A1 GUANIDINE DERIVATIVES ACTELION PHARMACEUTICALS LTD. (CH) 2005-03-17 WO claimed
US-20050054650-A1 Use of glutamate antagonists for the treatment of cancer IKONOMIDOU HRISSANTHI (DE) 2005-03-10 US claimed
US-6692643-B2 PREPARING BED OF MAGNETIC BEADS BY BINDING THIOPHILIC LIGANDS TO THE BEADS; INTRODUICING SAMPLE OF A FLUID BIOLOGICAL MATERIAL TO BE TESTED FOR PROSTATE SPECIFIC ANTIGEN (PSA) AND ITS PROTEIN COMPLEXES; MAGNETICALLY REMOVING BEADS HEALTH RESEARCH, INC. 2004-02-17 US claimed
US-20020166814-A1 Method for detecting PSA and its molecular forms using thiophilic gel on magnetic beads HEALTH RESEARCH, INC. 2002-11-14 US claimed
US-6379550-B1 CHROMATOGRAPHY HEALTH RESEARCH, INC. 2002-04-30 US claimed
EP-1189063-A1 Method for detecting PSA and its molecular forms using thiophilic gel HEALTH RESEARCH, INC. (US) 2002-03-20 EP claimed
EP-1124553-A1 NEW USE OF GLUTAMATE ANTAGONISTS FOR THE TREATMENT OF CANCER Ikonomidou, Hrissanthi (DE) 2001-08-22 EP claimed
EP-1002535-A1 New use of glutamate antagonists for the treatment of cancer Ikonomidou, Hrissanthi (DE) 2000-05-24 EP claimed
WO-2000024395-A1 NEW USE OF GLUTAMATE ANTAGONISTS FOR THE TREATMENT OF CANCER IKONOMIDOU HRISSANTHI (DE) 2000-05-04 WO claimed
US-5180735-A Antitumor agents, angiogenesis inhibitors TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-01-19 US claimed